NCT06347159Phase 2Active not recruiting

A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

Study sponsor: Edgewise Therapeutics, Inc. · EWTX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-12Estimated
Enrollment · participants79Estimated
Source updated2026-07-31Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment decreased by 21 participants

Before: 100 participants (planned). After: 79 participants (planned).

Primary completion date changed

Before: Jun 2026. After: Dec 2027.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 2 fields changed

Planned enrollment increased by 25 participants

Before: 75 participants (planned). After: 100 participants (planned).

Primary completion date changed

Before: Mar 2026. After: Jun 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview